Risk and Outcomes of Clostridium difficile Infection With Chronic Pancreatitis

被引:6
作者
Adejumo, Adeyinka Charles [1 ,2 ,3 ,4 ]
Adejumo, Kelechi Lauretta [4 ]
Pani, Lydie N. [1 ,2 ]
机构
[1] North Shore Med Ctr, Dept Med, 81 Highland Ave, Salem, MA 01970 USA
[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[3] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA
[4] Univ Massachusetts Lowell, Dept Publ Hlth, Lowell, MA USA
关键词
cost; mortality; discharge disposition; length of stay; kidney injury; INTESTINAL MICROBIOTA; REDUCED PREVALENCE; DISEASE; ANTIBIOTICS; MORTALITY; BURDEN;
D O I
10.1097/MPA.0000000000001380
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives Chronic pancreatitis (CP) is associated with high rates of recurrent hospitalizations, which predisposes to Clostridium difficile infection (CDI). We investigate the burden of CDI in CP. Methods We identified records of patients with CP from the Nationwide Inpatient Sample (NIS) 2012-2014 and estimated the impact of CDI on their outcomes. We calculated the adjusted odds ratio (AOR) of CP on having CDI (NIS 2014). From NIS 2007-2014, we plotted the trends of CDI and its interaction with CP. Results From 2012 to 2014, 886 (2.72%) of the 32,614 CP patients had concomitant CDI, which was associated with poorer outcomes: acute kidney injury (AOR, 2.57 [95% confidence interval {CI}, 2.11-3.13]), length of stay (13.3 vs 7.4 days), and charges (US $127,496 vs US $72,767), but not mortality (AOR, 0.93 [95% CI, 0.28-3.05]). In 2014, CP was associated with an increased risk of CDI (crude odds ratio, 2.10 [95% CI, 1.95-2.26]), which persisted after multivariate adjustment (AOR, 2.03 [95% CI, 1.87-2.19]). From 2007 to 2014, the annual prevalence of CDI was 106.4 cases per 10,000 hospitalizations, increasing from 2007 (95.5/10,000) to 2014 (118.4/10,000), with a 3.7 times higher annual rate of increase among CP versus no-CP patients (13.4/10,000 vs 3.7/10,000 population/year). Conclusions Chronic pancreatitis patients have high burden of CDI and may benefit from CDI prophylaxis.
引用
收藏
页码:1041 / 1049
页数:9
相关论文
共 47 条
  • [1] Among inpatients, ischemic bowel disease predisposes to Clostridium difficile infection with concomitant higher mortality and worse outcomes
    Adejumo, Adeyinka C.
    Akanbi, Olalekan
    Pani, Lydie
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 109 - 115
  • [2] Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease
    Adejumo, Adeyinka C.
    Ajayi, Tokunbo O.
    Adegbala, Oluwole M.
    Adejumo, Kelechi L.
    Alliu, Samson
    Akinjero, Akintunde M.
    Onyeakusi, Nnaemeka E.
    Ojelabi, Ogooluwa
    Bukong, Terence N.
    [J]. LIVER INTERNATIONAL, 2018, 38 (08) : 1475 - 1486
  • [3] Reduced Prevalence of Alcoholic Gastritis in Hospitalized Individuals Who Consume Cannabis
    Adejumo, Adeyinka Charles
    Li, Jingjing
    Akanbi, Olalekan
    Adejumo, Kelechi Lauretta
    Bukong, Terence Ndonyi
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 (02) : 270 - 276
  • [4] Protein-Energy Malnutrition and Outcomes of Hospitalizations for Heart Failure in the USA
    Adejumo, Adeyinka Charles
    Adejumo, Kelechi Lauretta
    Adegbala, Oluwole Muyiwa
    Chinedozi, Ifeanyichukwu
    Ndansi, Jordan
    Akanbi, Olalekan
    Onyeakusi, Nnaemeka Egbuna
    Ogundipe, Olumuyiwa Akinbolaji
    Bob-Manuel, Tamunoinemi
    Adeboye, Adedayo
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (06) : 929 - 935
  • [5] Reduced Risk of Alcohol-Induced Pancreatitis With Cannabis Use
    Adejumo, Adeyinka Charles
    Akanbi, Olalekan
    Adejumo, Kelechi Lauretta
    Bukong, Terence Ndonyi
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 (02) : 277 - 286
  • [6] Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis
    Adejumo, Adeyinka Charles
    Adegbala, Oluwole Muyiwa
    Adejumo, Kelechi Lauretta
    Bukong, Terence Ndonyi
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018
  • [7] Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study
    Adejumo, Adeyinka Charles
    Alliu, Samson
    Ajayi, Tokunbo Opeyemi
    Adejumo, Kelechi Lauretta
    Adegbale, Oluwole Muyiwa
    Onyeakusi, Nnaemeka Egbuna
    Akinjero, Akintunde Micheal
    Durojaiye, Modupeoluwa
    Bukong, Terence Ndonyi
    [J]. PLOS ONE, 2017, 12 (04):
  • [8] Orai1-Mediated Antimicrobial Secretion from Pancreatic Acini Shapes the Gut Microbiome and Regulates Gut Innate Immunity
    Ahuja, Malini
    Schwartz, Daniella M.
    Tandon, Mayank
    Son, Aran
    Zeng, Mei
    Swaim, William
    Eckhaus, Michael
    Hoffman, Victoria
    Cui, Yiyuan
    Xiao, Bo
    Worley, Paul F.
    Muallem, Shmuel
    [J]. CELL METABOLISM, 2017, 25 (03) : 635 - 646
  • [9] Sickle cell disease is associated with higher mortality among patients hospitalized with ischemic bowel disease
    Akanbi, Olalekan
    Adejumo, Adeyinka C.
    Saleem, Nasir
    Francisque, Frantz
    Soliman, Mohanad
    Ogunbayo, Gbolahan O.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (09) : 1027 - 1032
  • [10] Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease
    Ananthakrishnan, A. N.
    McGinley, E. L.
    Binion, D. G.
    [J]. GUT, 2008, 57 (02) : 205 - 210